Promo !

BAM-15 50 mg – 60 capsules

Le prix initial était : $99.00.Le prix actuel est : $95.00.

BAM-15 50 mg — 60 oral research capsules. BAM-15 is the most pharmacologically refined mitochondrial protonophore uncoupler ever developed — and the first such molecule with a meaningful safety margin over the historical leader 2,4-dinitrophenol (DNP). Identified in a chemical screen by the Hoehn group at the University of Virginia (Kenwood et al., Mol Metab 2014), BAM-15 selectively depolarizes the mitochondrial inner membrane without affecting the plasma membrane — the mechanistic distinction that eliminates the cardiovascular and thermogenic toxicity that has limited every prior uncoupler. In landmark 2020 work by Axelrod et al. (EMBO Mol Med), BAM-15 prevented diet-induced obesity and improved glycemic control in mice without behavioral or temperature toxicity, repositioning mitochondrial uncoupling as a credible therapeutic strategy for metabolic disease.

 

RESEARCH USE ONLY  ·  Not for human or veterinary use. For laboratory and collector purposes only.

 

Purity
≥ 99 % (HPLC) — third-party tested, CoA on file
Form
Research capsules
Content
50 mg BAM-15 per capsule
Total
60 capsules per bottle (3 g total)
Packaging
Sealed bottle with tamper-evident closure
Storage
Room temperature, dry, protected from light
Molecular formula
C₁₆H₁₀F₂N₆O
Molecular weight
≈ 340.29 g·mol⁻¹
IUPAC name
N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine
CAS number
210302-17-3
Synonyms
BAM 15; furazano[3,4-b]pyrazine uncoupler

 

Research Overview

BAM-15 (N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine) is a furazano-pyrazine protonophore that selectively shuttles protons across the mitochondrial inner membrane, dissipating the electrochemical gradient that drives ATP synthase and accelerating substrate oxidation through the electron transport chain [1]. In contrast to the historical reference compound DNP, BAM-15 does not depolarize the plasma membrane — a property attributable to its specific physicochemical profile and one that abolishes the cardiovascular toxicity (tachycardia, hyperthermia, sudden death) that ended DNP’s clinical use in the 1930s [1,2]. In the 2020 Axelrod et al. study, oral BAM-15 administered to diet-induced-obese mice produced robust weight loss and dramatic improvements in insulin sensitivity, glucose tolerance and hepatic steatosis without affecting food intake, body temperature or activity — clean separation from the toxicity profile of every prior uncoupler [2]. Subsequent work has demonstrated activity in models of acute kidney injury, sepsis, breast cancer proliferation and aging-related neurodegeneration in C. elegans (lifespan extension) [3]. BAM-15 is now the most clinically translatable mitochondrial uncoupler in the published literature.

 

Primary Research Areas

  • Mitochondrial uncoupling pharmacology — the cleanest and most mitochondria-selective protonophore in the published literature, superseding DNP, FCCP and CCCP for in-vivo mechanistic work [1,2].
  • Obesity and metabolic disease — robust weight-loss and glycemic-improvement signals in DIO mouse models with no thermogenic or cardiovascular toxicity, clearly differentiated from DNP [2].
  • Renal ischemia-reperfusion and AKI — protective in cold-storage, ischemic and septic acute kidney injury models, with mtROS reduction as a proximate mechanism [3].
  • Cancer metabolism research — investigated in TNBC and other proliferation-driven tumor models where mitochondrial vulnerability provides a targetable axis [3].
  • Aging and longevity — extends lifespan and rescues neurodegenerative phenotypes in C. elegans, providing a tractable invertebrate model of mitochondrial-uncoupling-driven longevity [3].

 

References

  1. Kenwood BM, Weaver JL, Bajwa A, et al. Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metab. 2014;3(2):114–123.
  2. Axelrod CL, King WT, Davuluri G, et al. BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control. EMBO Mol Med. 2020;12(7):e12088.
  3. Alexopoulos SJ, Chen SY, Brandon AE, et al. Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice. Nat Commun. 2020;11(1):2397.
Bile acid malabsorption (BAM) — also known as bile acid diarrhea (BAD) — is a digestive condition that occurs when the small intestine fails to properly reabsorb bile acids, causing them to spill into the colon. [1, 2]
How It Works
  • Normal Function: The liver makes bile acids to help digest and absorb fats in the small intestine, and about 95% of them are normally reabsorbed in the lower part of the small intestine (the ileum) to be recycled. [1]

  • The BAM Problem: When the ileum is damaged, diseased, or bypassed, or when the body produces too many bile acids, the excess bile spills into the large intestine (colon). [1, 2]

  • Colon Reaction: Excess bile in the colon irritates the lining, causing it to secrete water and electrolytes, which leads to rapid waste movement and chronic diarrhea. [1, 2]

Types of BAM

  • Type 1 (Secondary): Caused by disease or surgical removal of the ileum (such as in Crohn’s disease). [1, 2]

  • Type 2 (Primary / Idiopathic): Overproduction of bile acids by the liver or a defect in regulation (such as low FGF19) without prior bowel surgery. [1, 2]

  • Type 3 (Secondary): Caused by other gastrointestinal conditions like gallbladder removal (cholecystectomy), celiac disease, small intestinal bacterial overgrowth (SIBO), or chronic pancreatitis. [1, 2]

Common Symptoms

  • Chronic, urgent, watery, or pale/greasy diarrhea (often happening day and night)

  • Severe abdominal cramps, bloating, and excessive gas

  • Fecal urgency or bowel incontinence in severe cases

  • Fatigue, weight loss, or vitamin deficiencies (especially fat-soluble vitamins A, D, E, K, and sometimes B12) [1, 2, 3, 4]

Diagnosis and Treatment

  • Diagnosis: Evaluated through a SeHCAT scan, blood tests (like serum C4 or FGF19), or a trial of treatment.

  • Medication: Managed primarily with bile acid sequestrants (such as cholestyramine or colesevelam) that bind the excess bile acids.

  • Dietary Adjustments: Working with a specialist to follow a lower-fat diet and manage trigger foods. [1, 2, 3, 4, 5]

If you or someone you know is experiencing chronic digestive issues, let me know:
  • How long the symptoms have been happening
  • Whether there is a history of gallbladder surgery or bowel conditions

Why Limitless Biochem Shop?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “BAM-15 50 mg – 60 capsules”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list